In early September 2025, Eli Lilly launched Lilly TuneLab, an advanced AI/ML drug discovery platform, and reported positive ...

Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense. LOS ANGELES, CALIFORNIA / ...

In a recent Bloomberg Television interview, Demis Hassabis, CEO of DeepMind and Nobel laureate, revealed that AI could ...

A new AI Drug Discovery tool called PDGrapher can predict more accurate drug combinations up to 25 times faster than previous ...

Medicines Discovery Catapult (MDC) and Crown Bioscience have formed a strategic global collaboration to deliver an integrated translational biology platform for innovators developing ...

Traditionally, developing a new drug takes many years and requires a massive financial investment, often involving significant risk and a high likelihood of failure. AI models trained on extensive ...

The compounds that emerge aren't just theoretical curiosities. They're synthesised and tested, and one targeting fibrosis ...

Drug development and production rely on stringent quality controls, reproducibility, and verification. Biopharmaceuticals, including protein-based therapies, require extensive characterization, ...

BullFrog AI Holdings, Inc. has introduced bfLEAP™, an advanced platform designed to enhance the drug development process in biopharma by utilizing AI and machine learning for greater predictive ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Welcome to the latest edition of the Industry Focus eBook on Drug Discovery and Production, proudly sponsored by Sino Biological. In this edition, we offer a detailed look at the evolving landscape of ...

Six or more prescriptions of anti-epileptic drug, gabapentin, for low back pain are linked to a significantly higher risk of developing dementia and mild cognitive impairment. The corresponding study ...